Home Buprenorphine Induction: Evaluating a Primary Care Study
This paper critically evaluates Lee, Grossman et al.'s 2008 Journal of General Internal Medicine article examining home buprenorphine/naloxone induction in a New York City primary care setting. The review covers the study's background and significance within the broader opioid dependence treatment landscape, assesses the appropriateness of its literature review, analyzes the methodology used with 103 recruited patients, and examines the reported outcomes — including adverse effects, withdrawal symptoms, and treatment retention at 24 weeks. The paper concludes that the study's data are solid and its findings carry meaningful implications for both medical practice and regulatory policy regarding supervised versus unsupervised buprenorphine induction.
- Introduction and Background: Context of opioid dependence and buprenorphine treatment
- Literature Review: Assessment of cited sources on buprenorphine
- Method: Participant recruitment, design, and data reliability
- Results: Adverse effects, withdrawal rates, and retention outcomes
- Discussion: Policy implications of home induction findings
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The review is tightly focused: it evaluates each section of the source study (background, literature review, method, results, discussion) in a logical, organized sequence rather than offering vague general commentary.
- The author contextualizes the study's significance by grounding it in the broader opioid epidemic and existing regulatory guidelines, giving the reader the background necessary to appreciate why the findings matter.
- Reliability concerns about self-reported data are acknowledged and then resolved with evidence — the author notes that urine testing corroborated patient self-reports, demonstrating critical thinking about research methodology.
Key academic technique demonstrated
This paper demonstrates the technique of structured article critique: each major section of the source study is evaluated in turn using discipline-specific criteria (literature currency, sample composition, data reliability, comparability of outcomes). Rather than simply summarizing the study, the author asks whether methodological choices were justified and whether the conclusions are supported — a hallmark of graduate-level academic analysis.
Structure breakdown
The paper follows the IMRaD structure of the article it reviews: an introduction establishing context and significance, a literature review assessment, a method section evaluating participant recruitment and follow-up design, a results section focusing on adverse effects and retention rates, and a brief discussion linking findings to policy implications. This mirroring approach is a natural and effective choice for an article critique genre.
Introduction and Background
Lee, Grossman et al.'s 2008 Journal of General Internal Medicine article, "Home Buprenorphine/Naloxone Induction in Primary Care," is highly focused: the authors evaluate the success rates of a trial program at a New York City primary care clinic in which eligible patients underwent home buprenorphine induction without medical oversight. The significance of this focus depends upon certain background facts.
Opioid dependence — with manifestations ranging from daily heroin injection to abuse of prescription drugs such as OxyContin — has reached epidemic proportions across large areas of the United States. The difficulty of treating opioid dependence has led to strategies involving medically monitored use of less harmful substitutes, as in the familiar phenomenon of the "methadone clinic." Buprenorphine/naloxone, the partial mu-opioid receptor agonist under study, is a more recently developed substitute that shows tremendous promise: it can be obtained by prescription, allowing the patient to administer it independently, unlike methadone, which requires administration by medical personnel. However, current regulatory guidelines for induction "recommend directly observed initial dosing followed by multiple in-clinic visits during the induction week" (Lee et al., 2008, p. 226). The trial program evaluated in this paper instead implemented home induction: patients were given a prescription and allowed to begin the medication without the heavy supervision that is currently recommended.
References
Lee, J. D., Grossman, E., DiRocco, D., & Gourevitch, M. N. (2008). Home buprenorphine/naloxone induction in primary care. Journal of General Internal Medicine, 24, 226–232. https://doi.org/10.1007/s11606-008-0866-8
Create your account
Always verify citation format against your institution’s current style guide requirements.